ArsenalBio Revenue and Competitors

Location

#7165

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • ArsenalBio's estimated annual revenue is currently $71.8M per year.(i)
  • ArsenalBio's estimated revenue per employee is $217,000
  • ArsenalBio's total funding is $306M.

Employee Data

  • ArsenalBio has 331 Employees.(i)
  • ArsenalBio grew their employee count by 5% last year.

ArsenalBio's People

NameTitleEmail/Phone
1
VP, EngineeringReveal Email/Phone
2
VP QualityReveal Email/Phone
3
VP, Pre-Clinical PharmacologyReveal Email/Phone
4
VP, Program Management and AlliancesReveal Email/Phone
5
VP, Intellectual PropertyReveal Email/Phone
6
Head ProcurementReveal Email/Phone
7
VP, Molecular Biology and Protein EngineeringReveal Email/Phone
8
VP Early Product DevelopmentReveal Email/Phone
9
VP, Early DiscoveryReveal Email/Phone
10
VP, Corporate ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is ArsenalBio?

ArsenalBio was founded to discover, develop and commercialize curative immune cell therapies

keywords:N/A

$306M

Total Funding

331

Number of Employees

$71.8M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ArsenalBio News

2022-04-17 - Outbio chapter launched for LGBTQ biotech employees, allies ...

The group's sponsors so far include industry advocate California Life Sciences, Alumis, ArsenalBio, Genentech, Global Blood Therapeutics...

2022-04-06 - Alumis Expands Industry-Leading Leadership Team With ...

Schroer joins Alumis from ArsenalBio where he served as chief financial officer. Prior to that role, Mr. Schroer served as chief financial...

2019-10-17 - ArsenalBio Raises $85M in Series A Financing

ArsenalBio, a South San Francisco, Calif.-based programmable cell therapy company, raised $85m in Series A financing. Investors included Westlake Village BioPartners, the Parker Institute for Cancer Immunotherapy (PICI), Kleiner Perkins, the University of California, San Francisco (UCSF) Founda ...

2019-10-17 - ArsenalBio joins next-gen cell therapy field with $85M A round

ArsenalBio has exited stealth with $85 million to discover and develop cell therapies. The biotech aims to differentiate itself from the ever-growing pack of cell therapy startups with technology that enables the insertion of large DNA sequences without the use of viral vectors. The design and ...

2019-10-17 - ArsenalBio emerges from stealth with $85 million and a dream team to fight cancer

The story behind ArsenalBio begins with Sean Parker’s Institute for Cancer Immunotherapy. Founded in 2016, the Institute has been instrumental in providing a space for the top researchers into cancer across different fields to collaborate and communicate on the latest breakthroughs in settings ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$127.9M37910%N/A
#2
$130.6M387N/AN/A
#3
$12.8M403-5%$59.3M
#4
$35M4215%N/A
#5
$65.3M4217%N/A